3136 results for «2771»
3136 results
Rapid-fire - Other SHD interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Structural heart disease might present unusual complications during intervention. In this series of rapid-fire case submissions, learn about intervention on a pregnant patient, complete heart block post TAVR, and TAVR on a nonagerian female.
Valve-in-Valve
17 Feb 2024 – From PCR Tokyo Valves 2024
Discover various compelling cases of valve-in-valve interventions in this session: such as TAVI for a structural valve deterioration with winding snake-like aorta, the uses of tomography-fluoroscopy fusion imaging in bioprosthetic aortic valve cracking, and more!
CAD and TAVI
18 Feb 2024 – From PCR Tokyo Valves 2024
What is the clinical impact of CAD in TAVR recipients and how best to treat it? Through this session, gain insight on how to determine optimal CAD assessment in TAVR recipients, learn the timing of coronary revascularisation pre-TAVR, and understand the exact assessment and treatment of...
My patient with STEMI
15 May 2023 – From EAPCI-PCR Fellows course 2023
Consult these slides to understand the challenges of primary PCI, to discuss contemporary approaches to multivessel PCI in STEMI and to learn how to prevent and manage complications during primary PCI.
My patient with complex angiogram
15 May 2023 – From EAPCI-PCR Fellows course 2023
Consult these slides to learn how to efficiently perform intracoronary imaging and physiological assessment in your cath lab, to learn how to interpret IVUS and OCT images and to implement intracoronary physiology and imaging tools into the decision making in a MVD patient.
The EVOQUE and PASCAL Precision systems in action: simulation- and case-based learning
20 Nov 2023 – From PCR London Valves 2023
This session explores the features of the PASCAL Precision and the EVOQUE tricuspid replacement systems through simulators and case presentations, while a panel of experts discuss the technology, witnessing live demonstrations of treating mitral and tricuspid regurgitation patients.
Is only fixing functional mitral regurgitation in heart failure patients enough?
20 Nov 2023 – From PCR London Valves 2023
This session offers insights into combo therapy involving Carillon for patients with functional mitral regurgitation. It covers details of the EMPOWER trial, a double-blinded, sham-controlled study, and explores the potential benefits of early treatment for patients with functional mitral regurgitation.
Essentials of lifetime management of TAVI patients
20 Nov 2023 – From PCR London Valves 2023
In this session, discover the key features and benefits of next-generation transcatheter heart valve technology. Gain insights into managing bicuspid and valve-in-valve interventions, and understand the procedural and clinical significance of intermediate and XL sizes in addressing unmet clinical needs.
Expert roundtable: 4D ICE in tricuspid interventions
20 Nov 2023 – From PCR London Valves 2023
Join this session if you want to get familiar with the 4D ICE technology and the key elements of image guidance for tricuspid interventions, understand how 4D ICE can assist in specific procedural steps during challenging tricuspid interventions, and engage in an interactive discussion with experts...
Advancing valve repair: mastering diverse mitral and tricuspid regurgitation anatomies with the PASCAL Precision system
20 Nov 2023 – From PCR London Valves 2023
Participate in this session to stay informed about the latest clinical and real-world evidence for mitral and tricuspid TEER using PASCAL. Explore case-based discussions on mitral regurgitation treatment using PASCAL Precision, and actively participate in an educational tricuspid TEER recorded case procedure featuring the PASCAL Precision.
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
Defying complexity: achieving optimal TAVI procedural outcomes in challenging anatomies with the new Evolut FX
20 Nov 2023 – From PCR London Valves 2023
Watch this session to understand factors to consider when deciding on valve selection, recognize the significance of device choice and implantation technique in redo-TAVI, and acquire insights into anticipating challenges associated with implanting a bicuspid valve, large anatomy, and a horizontal aorta.
TAVI unleashed: optimisation of immediate and long-term outcomes
20 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to gain insights into the effects of paravalvular leak, conduction disturbances, stroke, and permanent pacemaker issues following transcatheter aortic valve implantation. The discussion also delves into the design of transcatheter heart valves and its implications for selecting the initial valve...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
Tricuspid transcatheter valve replacement: Cardiovalve keeps things in motion
20 Nov 2023 – From PCR London Valves 2023
Participate in this session to stay informed about the latest advancements in TTVR, receive updates on the Cardiovalve tricuspid program, and gain insights into how imaging demonstrates the concept underlying Cardiovalve transcatheter valve replacement technology.
Essentials of lifetime management of TAVI patients
21 Nov 2023 – From PCR London Valves 2023
Consult this session if you want to learn about the next generation transcatheter heart valve technology key features, procedural and clinical benefits, to learn tips and tricks for managing bicuspid and valve-in-valve interventions, and to understand procedural and clinical relevance of intermediate and XL sizes in...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
VitaFlow - The electrically enable self-expanding TAVI valve
21 Nov 2023 – From PCR London Valves 2023
This session provides insights into the unique design and advantages of VitaFlow Liberty for TAVI. It covers techniques to minimize microdislodgement during the procedure, identifies situations and patient types most suitable for VitaFlow Liberty, and reviews early clinical results associated with this technology.
Facing the challenges of resource shortages - An outlook into the future of TAVI?
21 Nov 2023 – From PCR London Valves 2023
Join this session to discover strategies for optimizing care quality and patient safety, especially in resource-constrained environments. Gain insights into variations in TAVI patient treatment across European countries, understanding the associated consequences. Engage in discussions exploring potential solutions to ensure long-term, high-quality patient care despite challenges...
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
